Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer.
作者:
主题词
老年人(Aged);碱性磷酸酶(Alkaline Phosphatase);雄甾烯类(Androstenes);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨肿瘤(Bone Neoplasms);无病生存(Disease-Free Survival);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);L-乳酸脱氢酶(L-Lactate Dehydrogenase);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);前列腺特异抗原(Prostate-Specific Antigen);治疗结果(Treatment Outcome)
DOI
10.1186/s12885-016-2260-y
PMID
26975660
发布时间
2024-05-25
- 浏览22
BMC cancer
214页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文